Novabay Pharmaceuticals Stock Price History
NBY Stock | USD 0.56 0.03 5.66% |
Below is the normalized historical share price chart for NovaBay Pharmaceuticals extending back to October 26, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of NovaBay Pharmaceuticals stands at 0.56, as last reported on the 13th of December 2024, with the highest price reaching 0.57 and the lowest price hitting 0.53 during the day.
If you're considering investing in NovaBay Stock, it is important to understand the factors that can impact its price. NovaBay Pharmaceuticals appears to be dangerous, given 3 months investment horizon. NovaBay Pharmaceuticals has Sharpe Ratio of 0.0598, which conveys that the firm had a 0.0598% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for NovaBay Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please exercise NovaBay Pharmaceuticals' Downside Deviation of 4.4, risk adjusted performance of 0.0545, and Mean Deviation of 4.28 to check out if our risk estimates are consistent with your expectations.
At this time, NovaBay Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 125.5 K in 2024, whereas Other Stockholder Equity is likely to drop slightly above 88.1 M in 2024. . Price Earnings To Growth Ratio is likely to rise to 0 in 2024, whereas Price To Sales Ratio is likely to drop 0.06 in 2024. NovaBay Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of October 2007 | 200 Day MA 2.0128 | 50 Day MA 0.652 | Beta 0.732 |
NovaBay |
Sharpe Ratio = 0.0598
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | NBY | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
7.85 actual daily | 69 69% of assets are less volatile |
Expected Return
0.47 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average NovaBay Pharmaceuticals is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NovaBay Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 2.4516 | Enterprise Value Ebitda (0.34) | Price Sales 0.2086 | Shares Float 4.9 M | Wall Street Target Price 3.725 |
NovaBay Pharmaceuticals Stock Price History Chart
There are several ways to analyze NovaBay Stock price data. The simplest method is using a basic NovaBay candlestick price chart, which shows NovaBay Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 12, 2024 | 0.78 |
Lowest Price | September 19, 2024 | 0.5 |
NovaBay Pharmaceuticals December 13, 2024 Stock Price Synopsis
Various analyses of NovaBay Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell NovaBay Stock. It can be used to describe the percentage change in the price of NovaBay Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of NovaBay Stock.NovaBay Pharmaceuticals Price Daily Balance Of Power | 0.75 | |
NovaBay Pharmaceuticals Price Rate Of Daily Change | 1.06 | |
NovaBay Pharmaceuticals Accumulation Distribution | 9,506 | |
NovaBay Pharmaceuticals Price Action Indicator | 0.03 |
NovaBay Pharmaceuticals December 13, 2024 Stock Price Analysis
NovaBay Stock Price History Data
The price series of NovaBay Pharmaceuticals for the period between Sat, Sep 14, 2024 and Fri, Dec 13, 2024 has a statistical range of 0.31 with a coefficient of variation of 12.83. The daily prices for the period are spread out with arithmetic mean of 0.64. The median price for the last 90 days is 0.65. The company underwent 1:35 stock split on 31st of May 2024.Open | High | Low | Close | Volume | ||
12/12/2024 | 0.53 | 0.57 | 0.53 | 0.56 | 135,462 | |
12/11/2024 | 0.58 | 0.58 | 0.52 | 0.53 | 186,382 | |
12/10/2024 | 0.57 | 0.60 | 0.57 | 0.59 | 34,060 | |
12/09/2024 | 0.60 | 0.60 | 0.58 | 0.59 | 56,793 | |
12/06/2024 | 0.57 | 0.60 | 0.57 | 0.58 | 54,375 | |
12/05/2024 | 0.58 | 0.60 | 0.57 | 0.58 | 40,265 | |
12/04/2024 | 0.58 | 0.59 | 0.55 | 0.57 | 66,123 | |
12/03/2024 | 0.60 | 0.60 | 0.55 | 0.57 | 86,411 | |
12/02/2024 | 0.60 | 0.61 | 0.58 | 0.60 | 48,778 | |
11/29/2024 | 0.61 | 0.61 | 0.59 | 0.60 | 21,161 | |
11/27/2024 | 0.59 | 0.62 | 0.56 | 0.59 | 88,511 | |
11/26/2024 | 0.62 | 0.64 | 0.60 | 0.61 | 111,665 | |
11/25/2024 | 0.67 | 0.68 | 0.60 | 0.62 | 197,110 | |
11/22/2024 | 0.72 | 0.72 | 0.68 | 0.68 | 31,802 | |
11/21/2024 | 0.71 | 0.73 | 0.68 | 0.72 | 40,587 | |
11/20/2024 | 0.68 | 0.73 | 0.68 | 0.71 | 33,236 | |
11/19/2024 | 0.70 | 0.72 | 0.69 | 0.70 | 31,822 | |
11/18/2024 | 0.71 | 0.72 | 0.69 | 0.70 | 60,863 | |
11/15/2024 | 0.74 | 0.74 | 0.69 | 0.71 | 93,577 | |
11/14/2024 | 0.73 | 0.75 | 0.70 | 0.73 | 80,347 | |
11/13/2024 | 0.78 | 0.81 | 0.71 | 0.71 | 271,399 | |
11/12/2024 | 0.72 | 0.82 | 0.70 | 0.78 | 270,261 | |
11/11/2024 | 0.71 | 0.74 | 0.66 | 0.71 | 104,083 | |
11/08/2024 | 0.72 | 0.72 | 0.64 | 0.69 | 209,878 | |
11/07/2024 | 0.73 | 0.74 | 0.67 | 0.70 | 322,203 | |
11/06/2024 | 0.74 | 0.76 | 0.70 | 0.72 | 1,089,628 | |
11/05/2024 | 0.76 | 0.77 | 0.74 | 0.76 | 152,911 | |
11/04/2024 | 0.73 | 0.79 | 0.70 | 0.76 | 315,613 | |
11/01/2024 | 0.75 | 0.75 | 0.68 | 0.75 | 106,501 | |
10/31/2024 | 0.76 | 0.76 | 0.70 | 0.72 | 313,147 | |
10/30/2024 | 0.64 | 0.75 | 0.61 | 0.75 | 1,184,570 | |
10/29/2024 | 0.63 | 0.72 | 0.57 | 0.65 | 17,890,084 | |
10/28/2024 | 0.55 | 0.56 | 0.55 | 0.55 | 96,395 | |
10/25/2024 | 0.56 | 0.60 | 0.54 | 0.55 | 56,177 | |
10/24/2024 | 0.59 | 0.60 | 0.55 | 0.57 | 108,115 | |
10/23/2024 | 0.58 | 0.62 | 0.58 | 0.59 | 98,094 | |
10/22/2024 | 0.60 | 0.62 | 0.54 | 0.59 | 142,386 | |
10/21/2024 | 0.63 | 0.67 | 0.61 | 0.62 | 223,603 | |
10/18/2024 | 0.57 | 0.63 | 0.57 | 0.63 | 89,173 | |
10/17/2024 | 0.59 | 0.61 | 0.58 | 0.59 | 114,330 | |
10/16/2024 | 0.61 | 0.63 | 0.58 | 0.59 | 200,715 | |
10/15/2024 | 0.61 | 0.64 | 0.61 | 0.61 | 98,150 | |
10/14/2024 | 0.62 | 0.64 | 0.60 | 0.62 | 96,963 | |
10/11/2024 | 0.63 | 0.64 | 0.61 | 0.62 | 106,225 | |
10/10/2024 | 0.65 | 0.65 | 0.62 | 0.62 | 80,020 | |
10/09/2024 | 0.70 | 0.70 | 0.65 | 0.65 | 104,098 | |
10/08/2024 | 0.69 | 0.69 | 0.68 | 0.68 | 41,610 | |
10/07/2024 | 0.71 | 0.72 | 0.68 | 0.69 | 98,530 | |
10/04/2024 | 0.74 | 0.75 | 0.70 | 0.71 | 112,866 | |
10/03/2024 | 0.69 | 0.74 | 0.67 | 0.74 | 188,988 | |
10/02/2024 | 0.66 | 0.70 | 0.66 | 0.70 | 196,564 | |
10/01/2024 | 0.67 | 0.71 | 0.64 | 0.68 | 281,169 | |
09/30/2024 | 0.70 | 0.70 | 0.65 | 0.69 | 229,963 | |
09/27/2024 | 0.70 | 0.73 | 0.68 | 0.71 | 320,645 | |
09/26/2024 | 0.69 | 0.74 | 0.68 | 0.73 | 562,339 | |
09/25/2024 | 0.71 | 0.71 | 0.67 | 0.69 | 478,828 | |
09/24/2024 | 0.75 | 0.78 | 0.70 | 0.71 | 1,032,708 | |
09/23/2024 | 0.74 | 0.81 | 0.67 | 0.75 | 4,234,064 | |
09/20/2024 | 0.87 | 1.01 | 0.62 | 0.74 | 145,331,464 | |
09/19/2024 | 0.51 | 0.52 | 0.49 | 0.50 | 52,167 | |
09/18/2024 | 0.53 | 0.54 | 0.50 | 0.51 | 79,361 |
About NovaBay Pharmaceuticals Stock history
NovaBay Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NovaBay is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NovaBay Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NovaBay Pharmaceuticals stock prices may prove useful in developing a viable investing in NovaBay Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 120.4 K | 125.5 K | |
Net Loss | -14.6 M | -15.4 M |
NovaBay Pharmaceuticals Stock Technical Analysis
NovaBay Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
All Next | Launch Module |
NovaBay Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NovaBay Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of NovaBay Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NovaBay to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0545 | |||
Jensen Alpha | 0.5966 | |||
Total Risk Alpha | (0.61) | |||
Sortino Ratio | 0.0839 | |||
Treynor Ratio | (0.38) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for NovaBay Stock Analysis
When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.